Table 2. Treatment data reported in available studies on GC from SSA.

Study reference number	Author	Country	Region/City	Study period	Regional population	Study cancer population	GC cases	Treatment
								Chemotherapy	Surgery	Radiation
[44]	Afuwape et al 2012	Nigeria		2004–2009	25,000,000		49		Curative = 10 Palliative = 13
[45]	Ahmed et al 2011	Nigeria	Zaria	1995–2009	9,375,000		179	57	Total = 155 (D1 = 37 and D2 = 50) Curative = 38 Palliative = 68
[49]	Asombang et al 2014	Zambia	Lusaka	2010–2012	4,384,000		51	6	Palliative = 12	6
[54]	Bang et al 2020	Cameroon		2013–2018	19,000,000	1,105	105	Curative = 30 Palliative = 77	Curative =32 Palliative = 16
[58]	Benamro 2017	South Africa	Durban	2009–2014	15,000,000		131	Curative = 21 Palliative = 40	Curative = 36 Curative = 1 Palliative = 12	17
[73]	Gaskill et al 2021	Ghana		2014–2015	30,000,000	2,562	98
[77]	Ibingira 2001	Uganda	Kampala	1995	964,000		32		Curative = 2 Palliative = 15 Diagnostic/Biopsy = 18
[6]	Mabula et al 2012	Tanzania	Mabula	2006–2011	13,000,000	5,134	232	Curative = 53	Curative = 53 (Total =1 and Partial =52) Palliative =120 Biopsy = 50
[85]	Martin et al 2018	Rwanda		2012–2016	51,000,000		229	Curative = 15 Palliative = 13	Curative = 30 Palliative = 87
[94]	Ntakiyiruta 2009	Rwanda		2006–2007	8,000,000		35		Curative = 1 Palliative = 34
[98]	Okobia 1999	Nigeria	Benin City	1989–1998	104,500,000	816	44